Title : Metformin prevents PFKFB3-related aerobic glycolysis from enhancing collagen synthesis in lung fibroblasts by regulating AMPK/mTOR pathway.

Pub. Date : 2021 Jun

PMID : 33850553






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin prevents PFKFB3-related aerobic glycolysis from enhancing collagen synthesis in lung fibroblasts by regulating AMPK/mTOR pathway. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Homo sapiens
2 The effects of metformin in AMP-activated protein kinase (AMPK) activation was assessed by mitochondrial complex I activity kits. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Homo sapiens
3 The effects of metformin in AMP-activated protein kinase (AMPK) activation was assessed by mitochondrial complex I activity kits. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Homo sapiens
4 Metformin significantly decreased mitochondrial complex I activity and upregulated the expression of p-AMPK/AMPK protein in a concentration-dependent manner. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Homo sapiens
5 However, this inhibitory role of metformin on PFKFB3-meditaed aerobic glycolysis and collagen synthesis was prevented by treatments with 3BDO and compound C, which are specific mTOR activator and AMPK inhibitor, respectively. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Homo sapiens
6 Taken together, the findings from this study suggested that metformin may prevent PFKFB3-associated aerobic glycolysis from enhancing collagen synthesis in lung fibroblasts via regulating the AMPK/mTOR pathway. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Homo sapiens